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service evaluation in 3 regional HSCTcentres (84 participants
in 8 professional groups).
Phase two:ALLINEX development & beta testing. Web-site
content was designed by health & psychosocial care
specialists in response to the outcomes of Phase I. Local &
national information resources were used to provide
content. Beta testing in patients (23), HSCT staff (24) & family
doctors (3) drove iterative development culminating in
a ﬁnal design for use in phase three.
Phase three: A randomised pilot study recruited patients
<2.5y post-HSCT with predicted minimum review of 2 clinic
visits within 12 weeks of informed consent. Stratiﬁed ran-
domisation (with/without Graft versus Host Disease) allo-
cated participants to SC or SC plus ALLINEX. Patient reported
outcomes including HADS, SDI-21 & EORTC QLQ-C30 were
collected at baseline & 12w post consent. Patients in the
intervention arm completed questionnaires on Patient
Acceptance & Use of Technology at 6w, ALLINEX feedback &
system usability scale at 12w & had website activity tracked.
All clinic visits were audio-recorded for simple content
analysis & additional contacts logged.
Results: Services evaluation identiﬁed gaps in service (e.g.
limited psychological support), standard services (e.g. open
access to transplant team) & reactive services (e.g.referrals to
psychiatry). Consequently, ALLINEX included information in
5 domains ranging from “everyday living” to “end of life,” an
interactive patient forum & a messaging system for con-
tacting the HSCT team. Beta testing resulted in minor
amendments.
Phase three recruitment was completed September 2012
with a participation rate of 71% & 50/53 patients completing
the study. Analysis is ongoing (due completion December
2012).
Conclusions: Involvement of patients & staff at all stages of
ALLINEX development has resulted in a website that per-
formed well in preliminary testing. Initial analysis indicates
that the site is relevant, accessible & comprehensive. Final
analysis may lead to changes in ALLINEX, guidance training
for patients & staff & further development of the interactive
aspects of the site.
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Objective: Hematopoietic stem cell transplantation (HSCT) is
a potentially curative therapy for malignant and autoim-
mune diseases. As the scope of transplant expands treatment
for more diseases and patient types, quality of life (QOL)
speciﬁcally fatigue, will remain an important measure for
outcome and long term survival in HSCT. Overall QOL is re-
ported to return to baseline or exceeds baseline by one year
while fatigue remains amajor symptom that is long lasting as
far out as 10 years.
Methods: A Pub Med search was completed in 2009 using
mesh terms, HSCT, bone marrow transplant, and quality of
life. This resulted in one hundred and seventy nine articles.
When fatigue was added to the mesh terms the number of
articles dropped to eleven. Highly relevant references were
chosen from articles and books. The National Comprehensive
Cancer Network (NCCN)websitewas also used as a source for
cancer related fatigue.
Results: Long term follow up studies of HSCT patients as far
out as ten years report fatigue as high as 35%. In comparative
trials with healthy controls this has been shown to be
statistically signiﬁcant. Multiple reasons may exist for this
prolonged decrement including chronic graft versus host
disease, preparative regimens, treatment prior to HSCT and
underlying disease. No studies to date have determined the
underlying etiology of long standing fatigue. Small studies
with exercise interventions and cognitive behavioral therapy
show promising results. These types of treatment may have
an impact on patients with fatigue following HSCT.
Conclusion: Multidimensional scales have been used to
measure fatigue in many QOL studies but few to date have
used fatigue speciﬁc scales. Multimodal interventions have
been shown to decrease the loss of aerobic ﬁtness, muscle
strength, and functional performance. Interventions with
exercise in addition to behavioral therapy with objective
physical measures and fatigue measurement scales may be
beneﬁcial in determining the cause of this chronic symptom
in patients post HSCT.
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